SCARLETRED

About:

SCARLETRED is a leading health AI company providing objective skin imaging and analysis SaaS for biopharma, dermatologists and patients

Website: http://www.scarletred.com

Twitter/X: scarletred

Top Investors: European Union, The Austrian Research Promotion Agency (FFG), EIT Health, austria Wirtschaftsservice (aws), Vienna Business Agency

Description:

SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connects to our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

Total Funding Amount:

4.55M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vienna, Wien, Austria

Founded Date:

2012-01-01

Contact Email:

office(AT)scarletred.com

Founders:

Schnidar Harald

Number of Employees:

11-50

Last Funding Date:

2020-06-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai